Fildena 100 Mg

Fildena 100 Mg
 mprovements in DBPC patient-reported consequences from baseline werestatistically noteworthy for both sildenafil 50 and 100 mg likened with
placebo. By the end of DBPC treatment, 56% of men on the 100-mg dose felt no
anxiety about the next intercourse attempt associated with 39% in the 50-mg
group (odds ratio 2.03; P = 0.0197). Changes in practical scores from baseline
were not statistically noteworthy with the 100-mg dose compared with the 50-mg
dose in the DBPC. Measures of action satisfaction and erotic experience
knowingly favored the 100-mg dose linked with the 50-mg dose in the DBPC. There
was no surge in adverse actions with the sophisticated dose.